Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Cautions on utilizing plasma GFAP level as a biomarker for reactive astrocytes in neurodegenerative diseases

Mol Neurodegener. 2025 May 9;20(1):54. doi: 10.1186/s13024-025-00846-9.

NO ABSTRACT

PMID:40346659 | DOI:10.1186/s13024-025-00846-9

Document this CPD

AI-Assisted Evidence Search

Share Evidence Blueprint

QR Code

Search Google Scholar

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review (RAISR4D)